| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | COL2A1 COL5A2 HSPG2 COL6A2 VWF FMOD PRELP LAMA2 LAMA3 LAMB3 SSPOP | 5.95e-12 | 188 | 58 | 11 | GO:0005201 |
| GeneOntologyMolecularFunction | structural molecule activity | COL2A1 COL5A2 HSPG2 COL6A2 VWF FMOD KRTAP3-3 PRELP KRTAP3-2 KRTAP3-1 LAMA2 LAMA3 LAMB3 SSPOP | 1.82e-07 | 891 | 58 | 14 | GO:0005198 |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring compression resistance | 3.95e-05 | 23 | 58 | 3 | GO:0030021 | |
| GeneOntologyMolecularFunction | calcium ion binding | 5.30e-05 | 749 | 58 | 10 | GO:0005509 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | 3.23e-04 | 46 | 58 | 3 | GO:0030020 | |
| GeneOntologyBiologicalProcess | development of secondary sexual characteristics | 6.56e-06 | 13 | 60 | 3 | GO:0045136 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | 1.29e-05 | 377 | 60 | 8 | GO:0030198 | |
| GeneOntologyBiologicalProcess | extracellular structure organization | 1.32e-05 | 378 | 60 | 8 | GO:0043062 | |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | 1.34e-05 | 379 | 60 | 8 | GO:0045229 | |
| GeneOntologyBiologicalProcess | olfactory learning | 8.27e-05 | 5 | 60 | 2 | GO:0008355 | |
| GeneOntologyBiologicalProcess | axon guidance | 1.77e-04 | 285 | 60 | 6 | GO:0007411 | |
| GeneOntologyBiologicalProcess | neuron projection guidance | 1.80e-04 | 286 | 60 | 6 | GO:0097485 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | TGFB1 COL2A1 VWC2 COL5A2 HSPG2 COL6A2 LAMB4 VWF FMOD PRELP LAMA2 LAMA3 LAMB3 SSPOP ADAMTSL4 | 1.76e-11 | 530 | 60 | 15 | GO:0062023 |
| GeneOntologyCellularComponent | extracellular matrix | TGFB1 COL2A1 VWC2 COL5A2 HSPG2 COL6A2 LAMB4 VWF FMOD PRELP LAMA2 LAMA3 LAMB3 SSPOP ADAMTSL4 | 3.46e-10 | 656 | 60 | 15 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | TGFB1 COL2A1 VWC2 COL5A2 HSPG2 COL6A2 LAMB4 VWF FMOD PRELP LAMA2 LAMA3 LAMB3 SSPOP ADAMTSL4 | 3.60e-10 | 658 | 60 | 15 | GO:0030312 |
| GeneOntologyCellularComponent | basement membrane | 5.79e-08 | 122 | 60 | 7 | GO:0005604 | |
| GeneOntologyCellularComponent | laminin-5 complex | 4.84e-05 | 4 | 60 | 2 | GO:0005610 | |
| GeneOntologyCellularComponent | collagen type XI trimer | 8.06e-05 | 5 | 60 | 2 | GO:0005592 | |
| GeneOntologyCellularComponent | Golgi lumen | 2.72e-04 | 109 | 60 | 4 | GO:0005796 | |
| GeneOntologyCellularComponent | laminin complex | 3.59e-04 | 10 | 60 | 2 | GO:0043256 | |
| GeneOntologyCellularComponent | fibrillar collagen trimer | 5.25e-04 | 12 | 60 | 2 | GO:0005583 | |
| GeneOntologyCellularComponent | banded collagen fibril | 5.25e-04 | 12 | 60 | 2 | GO:0098643 | |
| GeneOntologyCellularComponent | interstitial matrix | 1.07e-03 | 17 | 60 | 2 | GO:0005614 | |
| GeneOntologyCellularComponent | complex of collagen trimers | 1.64e-03 | 21 | 60 | 2 | GO:0098644 | |
| GeneOntologyCellularComponent | collagen trimer | 2.07e-03 | 88 | 60 | 3 | GO:0005581 | |
| GeneOntologyCellularComponent | platelet alpha granule | 2.43e-03 | 93 | 60 | 3 | GO:0031091 | |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | 2.62e-03 | 332 | 60 | 5 | GO:0005788 | |
| GeneOntologyCellularComponent | keratin filament | 2.74e-03 | 97 | 60 | 3 | GO:0045095 | |
| GeneOntologyCellularComponent | lysosomal lumen | 2.82e-03 | 98 | 60 | 3 | GO:0043202 | |
| HumanPheno | Shoulder contracture | 1.30e-05 | 11 | 23 | 3 | HP:0034665 | |
| HumanPheno | Upper-limb joint contracture | 1.40e-05 | 362 | 23 | 9 | HP:0100360 | |
| HumanPheno | Atrophic scars | 1.89e-05 | 37 | 23 | 4 | HP:0001075 | |
| HumanPheno | Lens dislocation | 3.47e-05 | 43 | 23 | 4 | HP:0000665 | |
| HumanPheno | Ectopia lentis | 3.47e-05 | 43 | 23 | 4 | HP:0001083 | |
| HumanPheno | Hoarse cry | 3.53e-05 | 15 | 23 | 3 | HP:0001615 | |
| HumanPheno | Abnormality of external features of the abdomen | 5.42e-05 | 326 | 23 | 8 | HP:0001462 | |
| HumanPheno | Scarring | 7.37e-05 | 102 | 23 | 5 | HP:0100699 | |
| HumanPheno | Dermal atrophy | 9.27e-05 | 107 | 23 | 5 | HP:0004334 | |
| HumanPheno | Flexion contracture of finger | 9.36e-05 | 257 | 23 | 7 | HP:0012785 | |
| HumanPheno | Finger joint contracture | 9.84e-05 | 259 | 23 | 7 | HP:0034681 | |
| HumanPheno | Abnormal phalangeal joint morphology of the hand | 1.06e-04 | 262 | 23 | 7 | HP:0006261 | |
| HumanPheno | Limb joint contracture | 1.11e-04 | 469 | 23 | 9 | HP:0003121 | |
| HumanPheno | Anisospondyly | 1.16e-04 | 4 | 23 | 2 | HP:0002879 | |
| HumanPheno | Spinal rigidity | 1.22e-04 | 59 | 23 | 4 | HP:0003306 | |
| HumanPheno | Abnormal blistering of the skin | 1.31e-04 | 115 | 23 | 5 | HP:0008066 | |
| HumanPheno | Duplicated collecting system | 1.53e-04 | 24 | 23 | 3 | HP:0000081 | |
| HumanPheno | Abnormality of the elbow | 1.68e-04 | 282 | 23 | 7 | HP:0009811 | |
| HumanPheno | Renal tubular epithelial necrosis | 1.93e-04 | 5 | 23 | 2 | HP:0008682 | |
| HumanPheno | Renal necrosis | 1.93e-04 | 5 | 23 | 2 | HP:0032618 | |
| HumanPheno | Pyoderma | 1.93e-04 | 5 | 23 | 2 | HP:0000999 | |
| HumanPheno | Blistering by anatomical location | 1.95e-04 | 26 | 23 | 3 | HP:0033800 | |
| HumanPheno | Abnormal fingertip morphology | 2.13e-04 | 203 | 23 | 6 | HP:0001211 | |
| HumanPheno | Kyphosis | 2.13e-04 | 510 | 23 | 9 | HP:0002808 | |
| HumanPheno | Urinary retention | 2.19e-04 | 27 | 23 | 3 | HP:0000016 | |
| HumanPheno | Joint contracture of the hand | 2.28e-04 | 296 | 23 | 7 | HP:0009473 | |
| HumanPheno | Waddling gait | 2.33e-04 | 130 | 23 | 5 | HP:0002515 | |
| HumanPheno | Lower-limb joint contracture | 2.43e-04 | 403 | 23 | 8 | HP:0005750 | |
| HumanPheno | Skin erosion | 2.45e-04 | 28 | 23 | 3 | HP:0200041 | |
| HumanPheno | Abnormal humeral metaphysis morphology | 2.89e-04 | 6 | 23 | 2 | HP:0003907 | |
| HumanPheno | Atypical scarring of skin | 2.95e-04 | 74 | 23 | 4 | HP:0000987 | |
| HumanPheno | Abnormal renal collecting system morphology | 3.02e-04 | 30 | 23 | 3 | HP:0004742 | |
| HumanPheno | Limitation of joint mobility | 3.92e-04 | 432 | 23 | 8 | HP:0001376 | |
| HumanPheno | Hypoplastic dermoepidermal hemidesmosomes | 4.04e-04 | 7 | 23 | 2 | HP:0020117 | |
| HumanPheno | Foot joint contracture | 4.80e-04 | 334 | 23 | 7 | HP:0008366 | |
| HumanPheno | Abnormality of upper limb joint | 5.03e-04 | 705 | 23 | 10 | HP:0009810 | |
| HumanPheno | Flexion contracture of finger | 5.27e-04 | 240 | 23 | 6 | HP:0005651 | |
| HumanPheno | Camptodactyly (hands) | 5.27e-04 | 240 | 23 | 6 | HP:0010563 | |
| HumanPheno | Joint contractures involving the joints of the feet | 5.27e-04 | 240 | 23 | 6 | HP:0100492 | |
| HumanPheno | Camptodactyly of finger | 5.27e-04 | 240 | 23 | 6 | HP:0100490 | |
| HumanPheno | Interphalangeal joint contracture of finger | 5.27e-04 | 240 | 23 | 6 | HP:0001220 | |
| HumanPheno | Camptodactyly of toe | 5.27e-04 | 240 | 23 | 6 | HP:0001836 | |
| HumanPheno | Flexion contracture of toe | 5.27e-04 | 240 | 23 | 6 | HP:0005830 | |
| HumanPheno | Anoperineal fistula | 5.37e-04 | 8 | 23 | 2 | HP:0005218 | |
| HumanPheno | Toe joint contracture | 5.39e-04 | 241 | 23 | 6 | HP:0034675 | |
| HumanPheno | Fragile skin | 5.65e-04 | 37 | 23 | 3 | HP:0001030 | |
| HumanPheno | Reduced forced vital capacity | 6.12e-04 | 38 | 23 | 3 | HP:0032341 | |
| HumanPheno | Ureteral obstruction | 6.61e-04 | 39 | 23 | 3 | HP:0006000 | |
| HumanPheno | Coxa valga | 6.78e-04 | 92 | 23 | 4 | HP:0002673 | |
| HumanPheno | Anal fistula | 6.89e-04 | 9 | 23 | 2 | HP:0010447 | |
| HumanPheno | Shoulder flexion contracture | 6.89e-04 | 9 | 23 | 2 | HP:0003044 | |
| HumanPheno | Congenital localized absence of skin | 6.89e-04 | 9 | 23 | 2 | HP:0007383 | |
| HumanPheno | Mitten deformity | 6.89e-04 | 9 | 23 | 2 | HP:0004057 | |
| HumanPheno | Elevated circulating aldolase concentration | 6.89e-04 | 9 | 23 | 2 | HP:0012544 | |
| HumanPheno | Limited elbow movement | 7.63e-04 | 168 | 23 | 5 | HP:0002996 | |
| HumanPheno | Vertebral clefting | 7.67e-04 | 41 | 23 | 3 | HP:0008428 | |
| HumanPheno | Flexion contracture of digit | 7.81e-04 | 362 | 23 | 7 | HP:0030044 | |
| HumanPheno | Recurrent bacterial skin infections | 8.23e-04 | 42 | 23 | 3 | HP:0005406 | |
| HumanPheno | Abnormal dermatological laboratory findings | 8.59e-04 | 10 | 23 | 2 | HP:0003340 | |
| HumanPheno | Lamina lucida cleavage | 8.59e-04 | 10 | 23 | 2 | HP:0003341 | |
| HumanPheno | Persistent pupillary membrane | 8.59e-04 | 10 | 23 | 2 | HP:0009917 | |
| HumanPheno | Cigarette-paper scars | 8.59e-04 | 10 | 23 | 2 | HP:0001073 | |
| HumanPheno | Abnormality of dental structure | 8.62e-04 | 368 | 23 | 7 | HP:0011061 | |
| HumanPheno | Carious teeth | 8.95e-04 | 174 | 23 | 5 | HP:0000670 | |
| HumanPheno | Subepidermal blistering | 1.05e-03 | 11 | 23 | 2 | HP:0033804 | |
| HumanPheno | Abnormal dermoepidermal hemidesmosome morphology | 1.05e-03 | 11 | 23 | 2 | HP:0032449 | |
| HumanPheno | Skin plaque | 1.15e-03 | 47 | 23 | 3 | HP:0200035 | |
| HumanPheno | Abnormal dermoepidermal junction morphology | 1.25e-03 | 12 | 23 | 2 | HP:0031538 | |
| HumanPheno | Weak cry | 1.29e-03 | 49 | 23 | 3 | HP:0001612 | |
| HumanPheno | Severe short stature | 1.37e-03 | 111 | 23 | 4 | HP:0003510 | |
| HumanPheno | Blistering by histological location | 1.48e-03 | 13 | 23 | 2 | HP:0033801 | |
| HumanPheno | Joint contractures | 1.48e-03 | 292 | 23 | 6 | HP:0001372 | |
| Domain | Laminin_EGF | 1.33e-13 | 35 | 59 | 8 | PF00053 | |
| Domain | EGF_Lam | 1.33e-13 | 35 | 59 | 8 | SM00180 | |
| Domain | VWFC_1 | 1.71e-13 | 36 | 59 | 8 | PS01208 | |
| Domain | VWC | 2.75e-13 | 38 | 59 | 8 | SM00214 | |
| Domain | VWFC_2 | 2.75e-13 | 38 | 59 | 8 | PS50184 | |
| Domain | Laminin_EGF | 2.75e-13 | 38 | 59 | 8 | IPR002049 | |
| Domain | VWF_dom | 6.57e-13 | 42 | 59 | 8 | IPR001007 | |
| Domain | EGF_1 | JAG2 HSPG2 LAMB4 THBD NELL2 CELSR2 DLL3 LAMA2 LAMA3 LAMB3 SSPOP MEGF11 STAB1 | 9.77e-13 | 255 | 59 | 13 | PS00022 |
| Domain | EGF_2 | JAG2 HSPG2 LAMB4 THBD NELL2 CELSR2 DLL3 LAMA2 LAMA3 LAMB3 SSPOP MEGF11 STAB1 | 1.59e-12 | 265 | 59 | 13 | PS01186 |
| Domain | EGF_LAM_2 | 4.18e-12 | 30 | 59 | 7 | PS50027 | |
| Domain | EGF_LAM_1 | 4.18e-12 | 30 | 59 | 7 | PS01248 | |
| Domain | EGF-like_CS | JAG2 HSPG2 LAMB4 THBD NELL2 CELSR2 DLL3 LAMA2 LAMA3 LAMB3 MEGF11 STAB1 | 2.69e-11 | 261 | 59 | 12 | IPR013032 |
| Domain | VWC | 2.73e-10 | 28 | 59 | 6 | PF00093 | |
| Domain | Growth_fac_rcpt_ | 1.38e-09 | 156 | 59 | 9 | IPR009030 | |
| Domain | VWC_out | 2.97e-09 | 19 | 59 | 5 | SM00215 | |
| Domain | EGF | 3.01e-09 | 235 | 59 | 10 | SM00181 | |
| Domain | EGF-like_dom | 5.25e-09 | 249 | 59 | 10 | IPR000742 | |
| Domain | Keratin_matx | 2.99e-08 | 3 | 59 | 3 | PF04579 | |
| Domain | EGF_3 | 4.93e-08 | 235 | 59 | 9 | PS50026 | |
| Domain | EGF_CA | 1.10e-07 | 122 | 59 | 7 | SM00179 | |
| Domain | Keratin_matx | 1.20e-07 | 4 | 59 | 3 | PD010562 | |
| Domain | EGF-like_Ca-bd_dom | 1.23e-07 | 124 | 59 | 7 | IPR001881 | |
| Domain | Laminin_N | 1.59e-07 | 16 | 59 | 4 | IPR008211 | |
| Domain | LAMININ_NTER | 1.59e-07 | 16 | 59 | 4 | PS51117 | |
| Domain | Laminin_N | 1.59e-07 | 16 | 59 | 4 | PF00055 | |
| Domain | LamNT | 1.59e-07 | 16 | 59 | 4 | SM00136 | |
| Domain | Laminin_G_2 | 1.60e-07 | 40 | 59 | 5 | PF02210 | |
| Domain | LamG | 2.61e-07 | 44 | 59 | 5 | SM00282 | |
| Domain | Keratin_matx | 2.98e-07 | 5 | 59 | 3 | IPR007659 | |
| Domain | - | 5.35e-07 | 95 | 59 | 6 | 2.60.120.200 | |
| Domain | Laminin_G | 1.07e-06 | 58 | 59 | 5 | IPR001791 | |
| Domain | EGF_extracell | 1.27e-06 | 60 | 59 | 5 | IPR013111 | |
| Domain | EGF_2 | 1.27e-06 | 60 | 59 | 5 | PF07974 | |
| Domain | LAMININ_IVA | 1.66e-06 | 8 | 59 | 3 | PS51115 | |
| Domain | Laminin_B | 1.66e-06 | 8 | 59 | 3 | PF00052 | |
| Domain | LamB | 1.66e-06 | 8 | 59 | 3 | SM00281 | |
| Domain | Laminin_IV | 1.66e-06 | 8 | 59 | 3 | IPR000034 | |
| Domain | hEGF | 1.74e-06 | 28 | 59 | 4 | PF12661 | |
| Domain | EGF | 2.81e-06 | 126 | 59 | 6 | PF00008 | |
| Domain | LAM_G_DOMAIN | 6.12e-06 | 38 | 59 | 4 | PS50025 | |
| Domain | Unchr_dom_Cys-rich | 8.37e-06 | 13 | 59 | 3 | IPR014853 | |
| Domain | C8 | 8.37e-06 | 13 | 59 | 3 | SM00832 | |
| Domain | TIL_dom | 1.06e-05 | 14 | 59 | 3 | IPR002919 | |
| Domain | VWD | 1.63e-05 | 16 | 59 | 3 | SM00216 | |
| Domain | VWF_type-D | 1.63e-05 | 16 | 59 | 3 | IPR001846 | |
| Domain | VWFD | 1.63e-05 | 16 | 59 | 3 | PS51233 | |
| Domain | VWD | 1.63e-05 | 16 | 59 | 3 | PF00094 | |
| Domain | TSP_1 | 4.65e-05 | 63 | 59 | 4 | PF00090 | |
| Domain | TSP1 | 5.27e-05 | 65 | 59 | 4 | SM00209 | |
| Domain | TSP1_rpt | 5.27e-05 | 65 | 59 | 4 | IPR000884 | |
| Domain | TSP1 | 5.27e-05 | 65 | 59 | 4 | PS50092 | |
| Domain | ConA-like_dom | 6.51e-05 | 219 | 59 | 6 | IPR013320 | |
| Domain | DSL | 9.75e-05 | 5 | 59 | 2 | IPR001774 | |
| Domain | Laminin_aI | 9.75e-05 | 5 | 59 | 2 | IPR009254 | |
| Domain | Laminin_I | 9.75e-05 | 5 | 59 | 2 | PF06008 | |
| Domain | Laminin_II | 9.75e-05 | 5 | 59 | 2 | PF06009 | |
| Domain | DSL | 9.75e-05 | 5 | 59 | 2 | PS51051 | |
| Domain | Notch_ligand_N | 9.75e-05 | 5 | 59 | 2 | IPR011651 | |
| Domain | Laminin_domII | 9.75e-05 | 5 | 59 | 2 | IPR010307 | |
| Domain | MNNL | 9.75e-05 | 5 | 59 | 2 | PF07657 | |
| Domain | LRRNT | 2.60e-04 | 98 | 59 | 4 | IPR000372 | |
| Domain | LRRNT | 2.60e-04 | 98 | 59 | 4 | SM00013 | |
| Domain | ASX_HYDROXYL | 2.81e-04 | 100 | 59 | 4 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 3.51e-04 | 106 | 59 | 4 | IPR000152 | |
| Domain | Fib_collagen_C | 5.30e-04 | 11 | 59 | 2 | IPR000885 | |
| Domain | COLFI | 5.30e-04 | 11 | 59 | 2 | PF01410 | |
| Domain | NC1_FIB | 5.30e-04 | 11 | 59 | 2 | PS51461 | |
| Domain | Laminin_G_1 | 5.30e-04 | 11 | 59 | 2 | PF00054 | |
| Domain | Fib_collagen_C | 5.30e-04 | 11 | 59 | 2 | PD002078 | |
| Domain | COLFI | 5.30e-04 | 11 | 59 | 2 | SM00038 | |
| Domain | LRRNT | 6.27e-04 | 53 | 59 | 3 | PF01462 | |
| Domain | TIL | 6.34e-04 | 12 | 59 | 2 | PF01826 | |
| Domain | C8 | 6.34e-04 | 12 | 59 | 2 | PF08742 | |
| Domain | TY | 1.29e-03 | 17 | 59 | 2 | SM00211 | |
| Domain | - | 1.29e-03 | 17 | 59 | 2 | 4.10.800.10 | |
| Domain | THYROGLOBULIN_1_2 | 1.29e-03 | 17 | 59 | 2 | PS51162 | |
| Domain | EMI | 1.29e-03 | 17 | 59 | 2 | PS51041 | |
| Domain | Thyroglobulin_1 | 1.29e-03 | 17 | 59 | 2 | IPR000716 | |
| Domain | Thyroglobulin_1 | 1.29e-03 | 17 | 59 | 2 | PF00086 | |
| Domain | THYROGLOBULIN_1_1 | 1.29e-03 | 17 | 59 | 2 | PS00484 | |
| Domain | CTCK_1 | 1.45e-03 | 18 | 59 | 2 | PS01185 | |
| Domain | Collagen | 2.46e-03 | 85 | 59 | 3 | IPR008160 | |
| Domain | Collagen | 2.46e-03 | 85 | 59 | 3 | PF01391 | |
| Domain | EGF_CA | 2.54e-03 | 86 | 59 | 3 | PF07645 | |
| Domain | Cys_knot_C | 2.81e-03 | 25 | 59 | 2 | IPR006207 | |
| Domain | CTCK_2 | 2.81e-03 | 25 | 59 | 2 | PS01225 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | 3.65e-12 | 84 | 44 | 9 | M7098 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 7.42e-11 | 76 | 44 | 8 | M27219 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 5.29e-10 | 59 | 44 | 7 | M27218 | |
| Pathway | KEGG_FOCAL_ADHESION | 8.59e-09 | 199 | 44 | 9 | M7253 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 2.15e-08 | 300 | 44 | 10 | M610 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 3.15e-08 | 30 | 44 | 5 | M27772 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 5.13e-08 | 66 | 44 | 6 | M18 | |
| Pathway | WP_FOCAL_ADHESION | 9.73e-08 | 187 | 44 | 8 | MM15913 | |
| Pathway | WP_FOCAL_ADHESION | 1.57e-07 | 199 | 44 | 8 | M39402 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 1.62e-07 | 41 | 44 | 5 | M27778 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 2.67e-07 | 143 | 44 | 7 | M27275 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 1.22e-06 | 61 | 44 | 5 | M27103 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 2.13e-06 | 30 | 44 | 4 | M27216 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | 3.66e-06 | 302 | 44 | 8 | M39719 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 4.45e-06 | 79 | 44 | 5 | M27643 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 4.46e-06 | 140 | 44 | 6 | M587 | |
| Pathway | PID_INTEGRIN4_PATHWAY | 4.60e-06 | 11 | 44 | 3 | M158 | |
| Pathway | KEGG_SMALL_CELL_LUNG_CANCER | 6.03e-06 | 84 | 44 | 5 | M3228 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 6.27e-06 | 39 | 44 | 4 | M27417 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 6.27e-06 | 39 | 44 | 4 | MM15165 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 6.39e-06 | 85 | 44 | 5 | M16441 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | 6.44e-06 | 326 | 44 | 8 | MM15917 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 8.46e-06 | 90 | 44 | 5 | M631 | |
| Pathway | WP_PI3KAKT_SIGNALING | 8.57e-06 | 339 | 44 | 8 | M39736 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 1.11e-05 | 250 | 44 | 7 | M27554 | |
| Pathway | WP_SMALL_CELL_LUNG_CANCER | 1.16e-05 | 96 | 44 | 5 | M39834 | |
| Pathway | PID_SYNDECAN_1_PATHWAY | 1.22e-05 | 46 | 44 | 4 | M198 | |
| Pathway | WP_CANCER_PATHWAYS | 2.16e-05 | 507 | 44 | 9 | M48302 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 3.12e-05 | 20 | 44 | 3 | MM15061 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 5.81e-05 | 68 | 44 | 4 | M27303 | |
| Pathway | REACTOME_INTEGRIN_CELL_SURFACE_INTERACTIONS | 8.99e-05 | 76 | 44 | 4 | MM14867 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 1.32e-04 | 32 | 44 | 3 | MM14924 | |
| Pathway | WP_ALPHA_6_BETA_4_SIGNALING | 1.45e-04 | 33 | 44 | 3 | M39503 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 2.22e-04 | 38 | 44 | 3 | MM14969 | |
| Pathway | REACTOME_DEFECTIVE_ST3GAL3_CAUSES_MCT12_AND_EIEE15 | 2.63e-04 | 8 | 44 | 2 | M27264 | |
| Pathway | REACTOME_DEFECTIVE_B4GALT1_CAUSES_B4GALT1_CDG_CDG_2D | 2.63e-04 | 8 | 44 | 2 | M27265 | |
| Pathway | REACTOME_DEFECTIVE_CHST6_CAUSES_MCDC1 | 2.63e-04 | 8 | 44 | 2 | M27262 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 2.78e-04 | 41 | 44 | 3 | MM15538 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_GLYCOSAMINOGLYCAN_METABOLISM | 2.78e-04 | 41 | 44 | 3 | M27257 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | TGFB1 COL2A1 COL5A2 COL6A2 NELL2 KMT2D KRTAP3-3 KRTAP3-2 KRTAP3-1 DLL3 LAMA2 EZH2 GFRA3 | 2.96e-04 | 1432 | 44 | 13 | M509 |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 2.99e-04 | 42 | 44 | 3 | M7169 | |
| Pathway | WP_SUPPRESSION_OF_HMGB1MEDIATED_INFLAMMATION_BY_THBD | 3.38e-04 | 9 | 44 | 2 | M39509 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_LIGAND_UBIQUITYLATION | 3.38e-04 | 9 | 44 | 2 | M47866 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 3.44e-04 | 44 | 44 | 3 | M27812 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 3.62e-04 | 109 | 44 | 4 | MM15164 | |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | 3.88e-04 | 111 | 44 | 4 | M27416 | |
| Pathway | PID_A6B1_A6B4_INTEGRIN_PATHWAY | 3.92e-04 | 46 | 44 | 3 | M239 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 4.18e-04 | 47 | 44 | 3 | MM14925 | |
| Pathway | KEGG_PATHWAYS_IN_CANCER | 4.84e-04 | 325 | 44 | 6 | M12868 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 5.02e-04 | 50 | 44 | 3 | MM14796 | |
| Pathway | REACTOME_TYPE_I_HEMIDESMOSOME_ASSEMBLY | 5.14e-04 | 11 | 44 | 2 | M27372 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 5.96e-04 | 53 | 44 | 3 | MM14566 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_SIGNALING_PATHWAY | 7.27e-04 | 13 | 44 | 2 | M47423 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 7.38e-04 | 57 | 44 | 3 | MM14713 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 7.77e-04 | 58 | 44 | 3 | M2049 | |
| Pathway | PID_NOTCH_PATHWAY | 8.16e-04 | 59 | 44 | 3 | M17 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | 8.50e-04 | 502 | 44 | 7 | MM14537 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 9.00e-04 | 61 | 44 | 3 | MM14637 | |
| Pathway | REACTOME_KERATAN_SULFATE_DEGRADATION | 9.74e-04 | 15 | 44 | 2 | M691 | |
| Pathway | REACTOME_ANCHORING_FIBRIL_FORMATION | 9.74e-04 | 15 | 44 | 2 | M27161 | |
| Pathway | REACTOME_KERATAN_SULFATE_DEGRADATION | 9.74e-04 | 15 | 44 | 2 | MM14799 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 9.89e-04 | 63 | 44 | 3 | M11187 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 1.03e-03 | 64 | 44 | 3 | M26953 | |
| Pathway | KEGG_MEDICUS_VARIANT_NOTCH_OVEREXPRESSION_TO_NOTCH_SIGNALING_PATHWAY | 1.11e-03 | 16 | 44 | 2 | M47424 | |
| Pathway | WP_ALPHA_6_BETA_4_INTEGRIN_SIGNALING_PATHWAY | 1.13e-03 | 66 | 44 | 3 | MM15925 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 1.18e-03 | 67 | 44 | 3 | M26999 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 1.20e-03 | 258 | 44 | 5 | MM14572 | |
| Pathway | WP_NOTCH1_REGULATION_OF_ENDOTHELIAL_CELL_CALCIFICATION | 1.26e-03 | 17 | 44 | 2 | M39389 | |
| Pathway | KEGG_COMPLEMENT_AND_COAGULATION_CASCADES | 1.29e-03 | 69 | 44 | 3 | M16894 | |
| Pathway | WP_INTERACTIONS_BETWEEN_LOXL4_AND_OXIDATIVE_STRESS_PATHWAY | 1.41e-03 | 18 | 44 | 2 | M39586 | |
| Pathway | WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER | 1.56e-03 | 161 | 44 | 4 | M39770 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 1.57e-03 | 19 | 44 | 2 | MM15512 | |
| Pathway | PID_AVB3_INTEGRIN_PATHWAY | 1.58e-03 | 74 | 44 | 3 | M160 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 1.70e-03 | 76 | 44 | 3 | MM14573 | |
| Pathway | PID_NFKAPPAB_CANONICAL_PATHWAY | 2.31e-03 | 23 | 44 | 2 | M37 | |
| Pathway | WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING | 3.18e-03 | 27 | 44 | 2 | M39545 | |
| Pathway | REACTOME_SYNDECAN_INTERACTIONS | 3.18e-03 | 27 | 44 | 2 | M27217 | |
| Pathway | REACTOME_KERATAN_SULFATE_BIOSYNTHESIS | 3.42e-03 | 28 | 44 | 2 | M670 | |
| Pathway | REACTOME_KERATAN_SULFATE_BIOSYNTHESIS | 3.42e-03 | 28 | 44 | 2 | MM14798 | |
| Pathway | WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY | 3.61e-03 | 99 | 44 | 3 | MM15905 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 3.92e-03 | 30 | 44 | 2 | MM15517 | |
| Pathway | WP_MICRORNAS_IN_CARDIOMYOCYTE_HYPERTROPHY | 4.15e-03 | 104 | 44 | 3 | M39625 | |
| Pathway | BIOCARTA_AGR_PATHWAY | 4.18e-03 | 31 | 44 | 2 | MM1343 | |
| Pathway | PID_SYNDECAN_2_PATHWAY | 4.73e-03 | 33 | 44 | 2 | M240 | |
| Pathway | WP_RESISTIN_AS_A_REGULATOR_OF_INFLAMMATION | 4.73e-03 | 33 | 44 | 2 | M39745 | |
| Pathway | BIOCARTA_AGR_PATHWAY | 4.73e-03 | 33 | 44 | 2 | M6220 | |
| Pubmed | 3.89e-12 | 146 | 60 | 9 | 27068509 | ||
| Pubmed | 1.99e-11 | 175 | 60 | 9 | 28071719 | ||
| Pubmed | 2.46e-10 | 153 | 60 | 8 | 25037231 | ||
| Pubmed | Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation. | 3.60e-10 | 97 | 60 | 7 | 27559042 | |
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 4.44e-10 | 248 | 60 | 9 | 24006456 | |
| Pubmed | 4.94e-10 | 167 | 60 | 8 | 22159717 | ||
| Pubmed | 3.02e-09 | 210 | 60 | 8 | 16537572 | ||
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 3.69e-09 | 135 | 60 | 7 | 28675934 | |
| Pubmed | Transcriptome-based systematic identification of extracellular matrix proteins. | 5.14e-09 | 79 | 60 | 6 | 18757743 | |
| Pubmed | Basement membrane composition in the early mouse embryo day 7. | 1.08e-08 | 15 | 60 | 4 | 15895400 | |
| Pubmed | 2.40e-08 | 18 | 60 | 4 | 11311202 | ||
| Pubmed | 4.87e-08 | 5 | 60 | 3 | 20684947 | ||
| Pubmed | 9.09e-08 | 64 | 60 | 5 | 22261194 | ||
| Pubmed | Chondromodulin I is dispensable during enchondral ossification and eye development. | 1.36e-07 | 27 | 60 | 4 | 12192060 | |
| Pubmed | Laminins promote the locomotion of skeletal myoblasts via the alpha 7 integrin receptor. | 1.70e-07 | 7 | 60 | 3 | 9004048 | |
| Pubmed | Structure, chromosomal location, and tissue-specific expression of the mouse opticin gene. | 1.70e-07 | 7 | 60 | 3 | 11527931 | |
| Pubmed | 1.84e-07 | 29 | 60 | 4 | 22613833 | ||
| Pubmed | 2.72e-07 | 8 | 60 | 3 | 11847210 | ||
| Pubmed | Comprehensive proteomic characterization of stem cell-derived extracellular matrices. | 4.03e-07 | 86 | 60 | 5 | 28327460 | |
| Pubmed | 5.81e-07 | 10 | 60 | 3 | 9034910 | ||
| Pubmed | Regional differences in the expression of laminin isoforms during mouse neural tube development. | 7.97e-07 | 11 | 60 | 3 | 21524702 | |
| Pubmed | 1.06e-06 | 12 | 60 | 3 | 16750824 | ||
| Pubmed | 1.06e-06 | 12 | 60 | 3 | 9396756 | ||
| Pubmed | 1.74e-06 | 50 | 60 | 4 | 23658023 | ||
| Pubmed | 2.19e-06 | 15 | 60 | 3 | 9264260 | ||
| Pubmed | 2.69e-06 | 16 | 60 | 3 | 36709857 | ||
| Pubmed | 2.69e-06 | 16 | 60 | 3 | 17601529 | ||
| Pubmed | 2.69e-06 | 16 | 60 | 3 | 16880404 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 30539787 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 21150180 | ||
| Pubmed | A comprehensive genetic linkage map of the human genome. NIH/CEPH Collaborative Mapping Group. | 2.93e-06 | 2 | 60 | 2 | 1439770 | |
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 32767843 | ||
| Pubmed | TGF-β enhances deposition of perlecan from COPD airway smooth muscle. | 2.93e-06 | 2 | 60 | 2 | 22003087 | |
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 24243921 | ||
| Pubmed | Structural requirement for cell adhesion to kalinin (laminin-5). | 2.93e-06 | 2 | 60 | 2 | 7775432 | |
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 10352025 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 19477487 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 8939648 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 27098652 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 33256984 | ||
| Pubmed | 2.93e-06 | 2 | 60 | 2 | 9205497 | ||
| Pubmed | 3.91e-06 | 18 | 60 | 3 | 12571105 | ||
| Pubmed | 5.45e-06 | 20 | 60 | 3 | 22911573 | ||
| Pubmed | 5.50e-06 | 257 | 60 | 6 | 16335952 | ||
| Pubmed | 6.35e-06 | 21 | 60 | 3 | 27856617 | ||
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 23631855 | ||
| Pubmed | Anthropometric and biochemical correlates of PAPP-A2, free IGF-I, and IGFBP-3 in childhood. | 8.77e-06 | 3 | 60 | 2 | 31961798 | |
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 15373767 | ||
| Pubmed | Valves of the deep venous system: an overlooked risk factor. | 8.77e-06 | 3 | 60 | 2 | 19436051 | |
| Pubmed | Laminin-5 suppresses chondrogenic differentiation of murine teratocarcinoma cell line ATDC5. | 8.77e-06 | 3 | 60 | 2 | 16165127 | |
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 8113417 | ||
| Pubmed | TGF-β-induced expression of IGFBP-3 regulates IGF1R signaling in human osteosarcoma cells. | 8.77e-06 | 3 | 60 | 2 | 23831640 | |
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 21843649 | ||
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 27375110 | ||
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 19036873 | ||
| Pubmed | Synthetic D-amino acid peptide inhibits tumor cell motility on laminin-5. | 8.77e-06 | 3 | 60 | 2 | 16537560 | |
| Pubmed | IGF-I and IGFBP-3 augment transforming growth factor-beta actions in human renal carcinoma cells. | 8.77e-06 | 3 | 60 | 2 | 16969385 | |
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 17275499 | ||
| Pubmed | Role of collagen type II and perlecan in skeletal development. | 8.77e-06 | 3 | 60 | 2 | 12814946 | |
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 34476481 | ||
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 17217840 | ||
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 22323620 | ||
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 8012114 | ||
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 9019243 | ||
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 22563463 | ||
| Pubmed | Laminin-332 (Laminin-5) is the major motility ligand for B cell chronic lymphocytic leukemia. | 8.77e-06 | 3 | 60 | 2 | 17482449 | |
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 28748258 | ||
| Pubmed | HANR promotes hepatocellular carcinoma progression via miR-214/EZH2/TGF-β axis. | 8.77e-06 | 3 | 60 | 2 | 30342849 | |
| Pubmed | Passive transfer of anti-laminin 5 antibodies induces subepidermal blisters in neonatal mice. | 8.77e-06 | 3 | 60 | 2 | 8833897 | |
| Pubmed | Expression and chain assembly of human laminin-332 in an insect cell-free translation system. | 8.77e-06 | 3 | 60 | 2 | 18603785 | |
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 33179081 | ||
| Pubmed | Fibroblasts contribute to the deposition of laminin 5 in the extracellular matrix. | 8.77e-06 | 3 | 60 | 2 | 15149852 | |
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 10085302 | ||
| Pubmed | TRIM13 regulates ubiquitination and turnover of NEMO to suppress TNF induced NF-κB activation. | 8.77e-06 | 3 | 60 | 2 | 25152375 | |
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 17376515 | ||
| Pubmed | Quantitative analysis of laminin 5 gene expression in human keratinocytes. | 8.77e-06 | 3 | 60 | 2 | 15854126 | |
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 11264294 | ||
| Pubmed | Uncoordinated production of Laminin-5 chains in airways epithelium of allergic asthmatics. | 8.77e-06 | 3 | 60 | 2 | 16179086 | |
| Pubmed | 8.77e-06 | 3 | 60 | 2 | 17137774 | ||
| Pubmed | Increased levels of endothelial haemostatic markers in patients with coronary heart disease. | 8.77e-06 | 3 | 60 | 2 | 11864703 | |
| Pubmed | Localization of pro-alpha 2(V) collagen transcripts in the tissues of the developing mouse embryo. | 8.77e-06 | 3 | 60 | 2 | 1297453 | |
| Pubmed | Differential expression of laminin-5 subunits during incisor and molar development in the mouse. | 8.77e-06 | 3 | 60 | 2 | 10853832 | |
| Pubmed | 8.87e-06 | 75 | 60 | 4 | 20637190 | ||
| Pubmed | 1.21e-05 | 81 | 60 | 4 | 39217171 | ||
| Pubmed | 1.23e-05 | 26 | 60 | 3 | 24742657 | ||
| Pubmed | Notch signalling pathway mediates hair cell development in mammalian cochlea. | 1.75e-05 | 4 | 60 | 2 | 10080181 | |
| Pubmed | 1.75e-05 | 4 | 60 | 2 | 12186868 | ||
| Pubmed | Dopamine modulates von Willebrand factor secretion in endothelial cells via D2-D4 receptors. | 1.75e-05 | 4 | 60 | 2 | 16839358 | |
| Pubmed | 1.75e-05 | 4 | 60 | 2 | 8081888 | ||
| Pubmed | 1.75e-05 | 4 | 60 | 2 | 1544908 | ||
| Pubmed | Fibromodulin Is Essential for Fetal-Type Scarless Cutaneous Wound Healing. | 1.75e-05 | 4 | 60 | 2 | 27665369 | |
| Pubmed | 1.75e-05 | 4 | 60 | 2 | 30078186 | ||
| Pubmed | 1.75e-05 | 4 | 60 | 2 | 10651091 | ||
| Pubmed | Bone morphogenetic protein 1 is an extracellular processing enzyme of the laminin 5 gamma 2 chain. | 1.75e-05 | 4 | 60 | 2 | 10806203 | |
| Pubmed | 1.75e-05 | 4 | 60 | 2 | 22673183 | ||
| Pubmed | 1.75e-05 | 4 | 60 | 2 | 24608043 | ||
| Pubmed | RNA-seq analysis to identify novel roles of scleraxis during embryonic mouse heart valve remodeling. | 1.75e-05 | 4 | 60 | 2 | 24983472 | |
| Pubmed | Ubiquitination of SARS-CoV-2 NSP6 and ORF7a Facilitates NF-κB Activation. | 1.75e-05 | 4 | 60 | 2 | 35856559 | |
| Pubmed | 1.75e-05 | 4 | 60 | 2 | 21034821 | ||
| Pubmed | Bisecting GlcNAc residues on laminin-332 down-regulate galectin-3-dependent keratinocyte motility. | 1.75e-05 | 4 | 60 | 2 | 19940114 | |
| Interaction | LCE3D interactions | 7.09e-08 | 73 | 59 | 6 | int:LCE3D | |
| Interaction | LCE3A interactions | 9.05e-08 | 76 | 59 | 6 | int:LCE3A | |
| Interaction | MMP2 interactions | 2.04e-07 | 87 | 59 | 6 | int:MMP2 | |
| Interaction | HOXA1 interactions | 8.74e-07 | 356 | 59 | 9 | int:HOXA1 | |
| Interaction | FBXO2 interactions | 2.85e-06 | 411 | 59 | 9 | int:FBXO2 | |
| Interaction | LCE4A interactions | 3.68e-06 | 80 | 59 | 5 | int:LCE4A | |
| Interaction | VASN interactions | 7.26e-06 | 160 | 59 | 6 | int:VASN | |
| Interaction | LCE1F interactions | 7.32e-06 | 92 | 59 | 5 | int:LCE1F | |
| Interaction | DEFB136 interactions | 8.24e-06 | 44 | 59 | 4 | int:DEFB136 | |
| Interaction | EDN3 interactions | 1.60e-05 | 108 | 59 | 5 | int:EDN3 | |
| Interaction | ADAM12 interactions | 2.50e-05 | 58 | 59 | 4 | int:ADAM12 | |
| Interaction | DEFB125 interactions | 2.62e-05 | 20 | 59 | 3 | int:DEFB125 | |
| Interaction | LCE3E interactions | 2.86e-05 | 60 | 59 | 4 | int:LCE3E | |
| Interaction | IL5RA interactions | 3.12e-05 | 124 | 59 | 5 | int:IL5RA | |
| Interaction | SLURP1 interactions | 6.38e-05 | 144 | 59 | 5 | int:SLURP1 | |
| Interaction | IGFL3 interactions | 6.90e-05 | 75 | 59 | 4 | int:IGFL3 | |
| Interaction | NICOL1 interactions | 8.38e-05 | 5 | 59 | 2 | int:NICOL1 | |
| Interaction | OTX1 interactions | 9.04e-05 | 155 | 59 | 5 | int:OTX1 | |
| Interaction | LCE2B interactions | 9.32e-05 | 81 | 59 | 4 | int:LCE2B | |
| Interaction | POU4F2 interactions | 1.02e-04 | 83 | 59 | 4 | int:POU4F2 | |
| Interaction | LCE1A interactions | 1.07e-04 | 84 | 59 | 4 | int:LCE1A | |
| Interaction | PRELP interactions | 1.11e-04 | 32 | 59 | 3 | int:PRELP | |
| Interaction | SIRPD interactions | 1.18e-04 | 86 | 59 | 4 | int:SIRPD | |
| Interaction | LCE5A interactions | 1.40e-04 | 90 | 59 | 4 | int:LCE5A | |
| Interaction | KRTAP4-11 interactions | 1.53e-04 | 92 | 59 | 4 | int:KRTAP4-11 | |
| Interaction | LTBP1 interactions | 1.53e-04 | 92 | 59 | 4 | int:LTBP1 | |
| Interaction | PAPPA2 interactions | 1.75e-04 | 7 | 59 | 2 | int:PAPPA2 | |
| Interaction | PRG2 interactions | 1.82e-04 | 285 | 59 | 6 | int:PRG2 | |
| Interaction | NUFIP2 interactions | 2.08e-04 | 417 | 59 | 7 | int:NUFIP2 | |
| Interaction | ATN1 interactions | 2.18e-04 | 187 | 59 | 5 | int:ATN1 | |
| Interaction | GNE interactions | 2.45e-04 | 104 | 59 | 4 | int:GNE | |
| Interaction | BMP1 interactions | 3.14e-04 | 111 | 59 | 4 | int:BMP1 | |
| Interaction | PCSK5 interactions | 3.25e-04 | 112 | 59 | 4 | int:PCSK5 | |
| Interaction | LYZL1 interactions | 3.96e-04 | 118 | 59 | 4 | int:LYZL1 | |
| Interaction | LAIR2 interactions | 3.99e-04 | 49 | 59 | 3 | int:LAIR2 | |
| Interaction | ZFHX2 interactions | 4.56e-04 | 11 | 59 | 2 | int:ZFHX2 | |
| Interaction | LYPD4 interactions | 4.64e-04 | 123 | 59 | 4 | int:LYPD4 | |
| Interaction | CACNA1A interactions | 4.64e-04 | 123 | 59 | 4 | int:CACNA1A | |
| Interaction | CATSPER1 interactions | 5.08e-04 | 126 | 59 | 4 | int:CATSPER1 | |
| Interaction | HTRA1 interactions | 5.32e-04 | 54 | 59 | 3 | int:HTRA1 | |
| Interaction | COL1A1 interactions | 5.39e-04 | 128 | 59 | 4 | int:COL1A1 | |
| Cytoband | 1q32 | 5.34e-07 | 49 | 60 | 4 | 1q32 | |
| Cytoband | 17q12-q21 | 1.02e-05 | 32 | 60 | 3 | 17q12-q21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr17q21 | 3.89e-04 | 473 | 60 | 5 | chr17q21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q32 | 5.76e-04 | 290 | 60 | 4 | chr1q32 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7p12 | 3.12e-03 | 63 | 60 | 2 | chr7p12 | |
| GeneFamily | Laminin subunits | 6.48e-09 | 12 | 36 | 4 | 626 | |
| GeneFamily | Collagens | 1.04e-04 | 46 | 36 | 3 | 490 | |
| GeneFamily | Small leucine rich repeat proteoglycans | 2.51e-04 | 12 | 36 | 2 | 573 | |
| GeneFamily | Keratin associated proteins | 1.32e-03 | 109 | 36 | 3 | 619 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 2.08e-03 | 34 | 36 | 2 | 487 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 5.74e-03 | 57 | 36 | 2 | 1179 | |
| GeneFamily | Ring finger proteins | 1.72e-02 | 275 | 36 | 3 | 58 | |
| Coexpression | NABA_CORE_MATRISOME | COL2A1 COL5A2 HSPG2 COL6A2 NELL2 VWF FMOD IGFBP3 SPOCK1 PRELP LAMA2 KCP LAMA3 LAMB3 C4BPA SSPOP | 1.03e-18 | 270 | 60 | 16 | MM17057 |
| Coexpression | NABA_CORE_MATRISOME | COL2A1 COL5A2 HSPG2 COL6A2 LAMB4 NELL2 VWF FMOD IGFBP3 SPOCK1 PRELP LAMA2 KCP LAMA3 LAMB3 SSPOP | 1.38e-18 | 275 | 60 | 16 | M5884 |
| Coexpression | NABA_MATRISOME | TGFB1 COL2A1 PAPPA2 VWC2 COL5A2 HSPG2 COL6A2 LAMB4 CPAMD8 NELL2 VWF FMOD IGFBP3 SPOCK1 PRELP LAMA2 KCP LAMA3 LAMB3 SSPOP ADAMTSL4 MEGF11 | 3.01e-16 | 1026 | 60 | 22 | M5889 |
| Coexpression | NABA_MATRISOME | TGFB1 COL2A1 PAPPA2 VWC2 COL5A2 HSPG2 COL6A2 NELL2 VWF FMOD IGFBP3 SPOCK1 PRELP LAMA2 KCP LAMA3 LAMB3 C4BPA SSPOP ADAMTSL4 MEGF11 | 3.01e-15 | 1008 | 60 | 21 | MM17056 |
| Coexpression | NABA_BASEMENT_MEMBRANES | 4.02e-10 | 40 | 60 | 6 | M5887 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 5.15e-10 | 191 | 60 | 9 | MM17059 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 6.47e-10 | 196 | 60 | 9 | M3008 | |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | 1.82e-08 | 200 | 60 | 8 | M5930 | |
| Coexpression | NABA_MATRISOME_BLEO_FIBROTIC_LUNG | 1.17e-07 | 20 | 60 | 4 | MM17053 | |
| Coexpression | KAAB_HEART_ATRIUM_VS_VENTRICLE_UP | 1.22e-07 | 256 | 60 | 8 | M10952 | |
| Coexpression | NABA_PROTEOGLYCANS | 1.23e-06 | 35 | 60 | 4 | M5882 | |
| Coexpression | NABA_PROTEOGLYCANS | 1.38e-06 | 36 | 60 | 4 | MM17061 | |
| Coexpression | BOQUEST_STEM_CELL_UP | 2.21e-06 | 261 | 60 | 7 | M1834 | |
| Coexpression | GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_52H_UP | 6.51e-06 | 200 | 60 | 6 | M9633 | |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CA_ENTEROENDOCRINE_CELLS | 7.12e-06 | 312 | 60 | 7 | M39161 | |
| Coexpression | LIU_PROSTATE_CANCER_DN | 1.61e-05 | 493 | 60 | 8 | M19391 | |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS | 1.95e-05 | 23 | 60 | 3 | M48001 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_LATE_MESOTHELIAL_CELL | 3.00e-05 | 704 | 60 | 9 | M45672 | |
| Coexpression | NABA_MATRISOME_METASTATIC_LUNG_LYMPH_NODE_METASTASIS | 3.99e-05 | 29 | 60 | 3 | MM17055 | |
| Coexpression | VALK_AML_CLUSTER_13 | 4.90e-05 | 31 | 60 | 3 | M2603 | |
| Coexpression | VECCHI_GASTRIC_CANCER_ADVANCED_VS_EARLY_UP | 5.51e-05 | 178 | 60 | 5 | M17079 | |
| Coexpression | DESCARTES_FETAL_EYE_STROMAL_CELLS | 5.71e-05 | 91 | 60 | 4 | M40180 | |
| Coexpression | RIGGI_EWING_SARCOMA_PROGENITOR_UP | 6.15e-05 | 437 | 60 | 7 | M15981 | |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 7.08e-05 | 35 | 60 | 3 | M11788 | |
| Coexpression | CLASPER_LYMPHATIC_VESSELS_DURING_METASTASIS_DN | 7.72e-05 | 36 | 60 | 3 | MM1212 | |
| Coexpression | HALLMARK_ANGIOGENESIS | 7.72e-05 | 36 | 60 | 3 | M5944 | |
| Coexpression | PEREZ_TP53_TARGETS | COL2A1 JAG2 COL5A2 ABHD15 LAMB4 STOX2 RNF166 IGFBP3 CELSR2 KCP MEGF11 | 7.75e-05 | 1201 | 60 | 11 | M4391 |
| Coexpression | GSE27786_BCELL_VS_CD8_TCELL_DN | 9.34e-05 | 199 | 60 | 5 | M4802 | |
| Coexpression | GSE4748_CTRL_VS_CYANOBACTERIUM_LPSLIKE_STIM_DC_1H_DN | 9.34e-05 | 199 | 60 | 5 | M6488 | |
| Coexpression | WOO_LIVER_CANCER_RECURRENCE_UP | 9.98e-05 | 105 | 60 | 4 | M12602 | |
| Coexpression | MIKKELSEN_DEDIFFERENTIATED_STATE_DN | 1.07e-04 | 7 | 60 | 2 | MM1260 | |
| Coexpression | MIKKELSEN_DEDIFFERENTIATED_STATE_DN | 1.07e-04 | 7 | 60 | 2 | M1927 | |
| Coexpression | NABA_COLLAGENS | 1.32e-04 | 43 | 60 | 3 | MM17060 | |
| Coexpression | NABA_COLLAGENS | 1.41e-04 | 44 | 60 | 3 | M3005 | |
| Coexpression | BOQUEST_STEM_CELL_DN | 1.43e-04 | 218 | 60 | 5 | M1578 | |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS | 1.51e-04 | 505 | 60 | 7 | M39167 | |
| Coexpression | WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP | 1.73e-04 | 121 | 60 | 4 | M8475 | |
| Coexpression | KOMMAGANI_TP63_GAMMA_TARGETS | 1.84e-04 | 9 | 60 | 2 | M9630 | |
| Coexpression | FAN_EMBRYONIC_CTX_BIG_GROUPS_BRAIN_ENDOTHELIAL | 1.86e-04 | 365 | 60 | 6 | M39018 | |
| Coexpression | DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_UP | 1.94e-04 | 368 | 60 | 6 | M16431 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C3_LYMPHATIC_ENDOTHELIAL_CELL | 2.38e-04 | 382 | 60 | 6 | M45756 | |
| Coexpression | CROMER_TUMORIGENESIS_UP | 3.22e-04 | 58 | 60 | 3 | M178 | |
| Coexpression | HAY_BONE_MARROW_STROMAL | 3.46e-04 | 767 | 60 | 8 | M39209 | |
| Coexpression | BROWNE_HCMV_INFECTION_6HR_UP | 4.11e-04 | 63 | 60 | 3 | M14728 | |
| Coexpression | ANASTASSIOU_MULTICANCER_INVASIVENESS_SIGNATURE | 4.30e-04 | 64 | 60 | 3 | M2572 | |
| Coexpression | CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_HYPOMETHYLATED_AND_UP | 5.24e-04 | 162 | 60 | 4 | M45037 | |
| Coexpression | VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP | 5.36e-04 | 163 | 60 | 4 | M12112 | |
| Coexpression | WANG_MLL_TARGETS | 5.66e-04 | 294 | 60 | 5 | M2456 | |
| Coexpression | GU_PDEF_TARGETS_UP | 5.83e-04 | 71 | 60 | 3 | M3955 | |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 6.06e-04 | 16 | 60 | 2 | MM1296 | |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 6.06e-04 | 16 | 60 | 2 | M2207 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_0 | 6.08e-04 | 72 | 60 | 3 | M15699 | |
| Coexpression | GSE37533_UNTREATED_VS_PIOGLIZATONE_TREATED_CD4_TCELL_FOXP3_TRASDUCED_CD4_TCELL_UP | 6.28e-04 | 170 | 60 | 4 | M8994 | |
| Coexpression | WANG_MLL_TARGETS | 6.78e-04 | 306 | 60 | 5 | MM1076 | |
| Coexpression | DI_MARTINO_MATRISOME_HIGHLY_PROLIFERATIVE_HNSCC_TUMOR_CELL_DERIVED | 6.85e-04 | 17 | 60 | 2 | M47995 | |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3 | 7.10e-04 | 1074 | 60 | 9 | M1941 | |
| Coexpression | YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_0 | 7.68e-04 | 78 | 60 | 3 | MM867 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | 7.85e-04 | 479 | 60 | 6 | M2573 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | 8.19e-04 | 483 | 60 | 6 | MM1082 | |
| Coexpression | VERRECCHIA_RESPONSE_TO_TGFB1_C1 | 8.59e-04 | 19 | 60 | 2 | M16026 | |
| Coexpression | ATF2_S_UP.V1_DN | 8.96e-04 | 187 | 60 | 4 | M2681 | |
| Coexpression | CYCLIN_D1_UP.V1_UP | 8.96e-04 | 187 | 60 | 4 | M2654 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HENDO | 9.05e-04 | 888 | 60 | 8 | M39049 | |
| Coexpression | MURARO_PANCREAS_MESENCHYMAL_STROMAL_CELL | 9.06e-04 | 681 | 60 | 7 | M39175 | |
| Coexpression | CYCLIN_D1_KE_.V1_UP | 9.14e-04 | 188 | 60 | 4 | M2648 | |
| Coexpression | SWEET_KRAS_TARGETS_UP | 9.20e-04 | 83 | 60 | 3 | M2448 | |
| Coexpression | YAO_HOXA10_TARGETS_VIA_PROGESTERONE_UP | 9.20e-04 | 83 | 60 | 3 | M10660 | |
| Coexpression | GSE21546_UNSTIM_VS_ANTI_CD3_STIM_SAP1A_KO_AND_ELK1_KO_DP_THYMOCYTES_UP | 9.32e-04 | 189 | 60 | 4 | M7539 | |
| Coexpression | ZHU_CMV_24_HR_DN | 9.52e-04 | 84 | 60 | 3 | M4065 | |
| Coexpression | ZHONG_PFC_C8_UNKNOWN_NEUROD2_POS_INTERNEURON | 9.52e-04 | 84 | 60 | 3 | M39095 | |
| Coexpression | LAMB_CCND1_TARGETS | 9.53e-04 | 20 | 60 | 2 | M2935 | |
| Coexpression | SANA_TNF_SIGNALING_DN | 9.86e-04 | 85 | 60 | 3 | M19467 | |
| Coexpression | SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_DN | 9.86e-04 | 85 | 60 | 3 | M7012 | |
| Coexpression | SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1A | 1.05e-03 | 21 | 60 | 2 | M1501 | |
| Coexpression | GSE26559_TCF1_KO_VS_WT_LIN_NEG_CELL_DN | 1.07e-03 | 196 | 60 | 4 | M8422 | |
| Coexpression | GSE26290_WT_VS_PDK1_KO_ANTI_CD3_AND_IL2_STIM_CD8_TCELL_DN | 1.09e-03 | 197 | 60 | 4 | M8136 | |
| Coexpression | GSE2706_UNSTIM_VS_8H_LPS_AND_R848_DC_DN | 1.09e-03 | 197 | 60 | 4 | M4705 | |
| Coexpression | GSE36476_YOUNG_VS_OLD_DONOR_MEMORY_CD4_TCELL_DN | 1.11e-03 | 198 | 60 | 4 | M5307 | |
| Coexpression | GSE3982_MAC_VS_NKCELL_DN | 1.11e-03 | 198 | 60 | 4 | M5509 | |
| Coexpression | GSE17721_POLYIC_VS_CPG_24H_BMDC_UP | 1.11e-03 | 198 | 60 | 4 | M3953 | |
| Coexpression | GSE19941_UNSTIM_VS_LPS_STIM_IL10_KO_MACROPHAGE_UP | 1.13e-03 | 199 | 60 | 4 | M8105 | |
| Coexpression | GSE24210_IL35_TREATED_VS_RESTING_TREG_DN | 1.13e-03 | 199 | 60 | 4 | M7843 | |
| Coexpression | GSE41176_WT_VS_TAK1_KO_UNSTIM_BCELL_DN | 1.13e-03 | 199 | 60 | 4 | M9941 | |
| Coexpression | GSE29618_PRE_VS_DAY7_POST_TIV_FLU_VACCINE_PDC_UP | 1.15e-03 | 200 | 60 | 4 | M5003 | |
| Coexpression | GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_20H_DN | 1.15e-03 | 200 | 60 | 4 | M9647 | |
| Coexpression | GSE43955_TH0_VS_TGFB_IL6_TH17_ACT_CD4_TCELL_1H_DN | 1.15e-03 | 200 | 60 | 4 | M9637 | |
| Coexpression | HALLMARK_APICAL_JUNCTION | 1.15e-03 | 200 | 60 | 4 | M5915 | |
| Coexpression | HALLMARK_MYOGENESIS | 1.15e-03 | 200 | 60 | 4 | M5909 | |
| Coexpression | GSE360_LOW_DOSE_B_MALAYI_VS_M_TUBERCULOSIS_DC_UP | 1.15e-03 | 200 | 60 | 4 | M5229 | |
| Coexpression | GSE41176_UNSTIM_VS_ANTI_IGM_STIM_TAK1_KO_BCELL_3H_DN | 1.15e-03 | 200 | 60 | 4 | M9930 | |
| Coexpression | GSE17721_0.5H_VS_24H_CPG_BMDC_UP | 1.15e-03 | 200 | 60 | 4 | M4128 | |
| Coexpression | GSE6092_UNSTIM_VS_IFNG_STIM_AND_B_BURGDORFERI_INF_ENDOTHELIAL_CELL_DN | 1.15e-03 | 200 | 60 | 4 | M6715 | |
| Coexpression | GSE2405_0H_VS_1.5H_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_UP | 1.15e-03 | 200 | 60 | 4 | M6209 | |
| Coexpression | GSE17721_POLYIC_VS_PAM3CSK4_4H_BMDC_DN | 1.15e-03 | 200 | 60 | 4 | M3833 | |
| Coexpression | GSE2770_UNTREATED_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_2H_UP | 1.15e-03 | 200 | 60 | 4 | M6047 | |
| Coexpression | GSE7831_UNSTIM_VS_CPG_STIM_PDC_1H_DN | 1.15e-03 | 200 | 60 | 4 | M6945 | |
| Coexpression | GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_UP | 1.16e-03 | 22 | 60 | 2 | M7184 | |
| Coexpression | YAO_HOXA10_TARGETS_VIA_PROGESTERONE_UP | 1.20e-03 | 91 | 60 | 3 | MM622 | |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | 5.99e-06 | 466 | 60 | 9 | GSM777050_500 | |
| CoexpressionAtlas | JC_hmvEC_top-relative-expression-ranked_1000_k-means-cluster#1 | 1.30e-05 | 107 | 60 | 5 | JC_hmvEC_1000_K1 | |
| CoexpressionAtlas | Stromal Cells, St.31-38-44-.SLN, CD45- gp38- CD31- CD44-, Lymph Node, avg-2 | 3.90e-05 | 453 | 60 | 8 | GSM777067_500 | |
| CoexpressionAtlas | Stromal Cells, FRC.SLN, gp38+ CD31- CD140a+, Lymph Node, avg-4 | 4.03e-05 | 455 | 60 | 8 | GSM777055_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_200 | 5.78e-05 | 146 | 60 | 5 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000 | 7.92e-05 | 806 | 60 | 10 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000 | |
| CoexpressionAtlas | ratio_induced-Mesoderm_vs_StemCell_top-relative-expression-ranked_1000 | TGFB1 COL2A1 COL5A2 THBD VWF TTLL3 SPOCK1 PRELP KCP LAMB3 SSPOP | 8.36e-05 | 982 | 60 | 11 | PCBC_ratio_MESO-5_vs_SC_1000 |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | 1.64e-04 | 97 | 60 | 4 | GSM777043_100 | |
| CoexpressionAtlas | Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4 | 2.25e-04 | 437 | 60 | 7 | GSM777046_500 | |
| CoexpressionAtlas | Mesoderm Day 5_vs_Endoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05 | 2.82e-04 | 320 | 60 | 6 | PCBC_ratio_MESO-5_vs_DE_cfr-2X-p05 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder stroma (LCM)_emap-30396_top-relative-expression-ranked_1000 | 3.30e-04 | 783 | 60 | 9 | gudmap_developingLowerUrinaryTract_P2_bladder stroma (LCM)_1000 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_distal_ERK2_WT_2500_K3 | 3.82e-04 | 121 | 60 | 4 | facebase_RNAseq_e14.5_palate_poster_distal_ERK2_WT_2500_K3 | |
| CoexpressionAtlas | JC_hmvEC_top-relative-expression-ranked_500_k-means-cluster#1 | 3.84e-04 | 219 | 60 | 5 | JC_hmvEC_500_K1 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.77e-10 | 189 | 60 | 8 | eccf3d49354a67c94f1ed7c15a98a48a5e8e2ed0 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.77e-10 | 189 | 60 | 8 | 40764f461b8aa1d3a2c5a30590b7fb9307d47d09 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.09e-09 | 182 | 60 | 7 | fbd5e332df73bf7141c822fa67b76367dc962017 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro-stroma-arteriolar_fibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 7.11e-09 | 191 | 60 | 7 | 5271198116343c07202649889057e5774d7fdde3 | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_fibro-stroma-endosteal_fibroblast|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 7.11e-09 | 191 | 60 | 7 | 44b1f62fdee03b157fe545f2ae6ff84f8929a8ac | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.37e-09 | 192 | 60 | 7 | 671d4e1eee5aba03c43dbc98f4b51ce42b3df5d5 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.37e-09 | 192 | 60 | 7 | 840a34c1b82d218be999ab5e1bcafd6370d7a4b1 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal-mesenchymal-mesenchymal_stem_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.80e-09 | 197 | 60 | 7 | 3bb92dd8a94e2be3b7fe51c9a21b241215477ac7 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.80e-09 | 197 | 60 | 7 | 17344464fdcc5ba0c03959696b97c195f11e644c | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-mesenchymal-mesenchymal|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 8.80e-09 | 197 | 60 | 7 | 5b8d0d7116b20d8e27541e88ec80c9f1f477e384 | |
| ToppCell | 5'-Adult-Distal_Rectal-Endothelial-blood_vessel_EC-Mature_arterial_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.11e-09 | 198 | 60 | 7 | 8a55589b9244283e4b0b423a4a6d6202e8e0fec9 | |
| ToppCell | 5'-Adult-SmallIntestine-Endothelial-blood_vessel_EC-Mature_arterial_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.11e-09 | 198 | 60 | 7 | 58508a8df2714d769f137794c29441a7bd38b350 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-D-|368C / Donor, Lineage, Cell class and subclass (all cells) | 9.44e-09 | 199 | 60 | 7 | 5a425e7d11c5911ff5855c27a7f058a7ed7abbb0 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-D|368C / Donor, Lineage, Cell class and subclass (all cells) | 9.44e-09 | 199 | 60 | 7 | 66545eb7f65e450b742628fd431956e13330a0d3 | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-2,_SCARA5-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.77e-09 | 200 | 60 | 7 | 0b2614b8513693dd508c9003699049efd9abac52 | |
| ToppCell | Biopsy_Other_PF-Mesenchymal-Fibroblasts|Biopsy_Other_PF / Sample group, Lineage and Cell type | 9.77e-09 | 200 | 60 | 7 | 9996b6887cf2b1936e10a1aa396f09fd8da5f4c4 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Endothelial-blood_vessel_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.77e-09 | 200 | 60 | 7 | 392abf38afc874925618397ae320a630e18b8e0a | |
| ToppCell | Bronchial-10x5prime-Endothelial-Endothelia_vascular-VE_pulmonary_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.77e-09 | 200 | 60 | 7 | 7547d6339f9380d031cfd2cce21ac9a12491e085 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-B_(Myofibroblast)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 9.77e-09 | 200 | 60 | 7 | 082e718c1da3f4fdd33a001d15ad3ddb2be985c7 | |
| ToppCell | Lung_Parenchyma-Severe-Mesenchymal-Mesenchymal-Fibroblasts-2,_SCARA5|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.77e-09 | 200 | 60 | 7 | 8d2ceb2080c67b20f452eeca605aa27a58033c04 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-B_(Myofibroblast)|367C / Donor, Lineage, Cell class and subclass (all cells) | 9.77e-09 | 200 | 60 | 7 | 731e55070a7ff315091855bd88cda30e5a7e1a98 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Endothelial|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.77e-09 | 200 | 60 | 7 | fc0fd7b8e16eb593698084dca3f566d4d4bff381 | |
| ToppCell | Parenchyma_COVID-19-Stromal-TX-Fibroblasts-2,_SCARA5|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 9.77e-09 | 200 | 60 | 7 | c338a08c1605527ab9aaf62ea151a19e8469dc6d | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.21e-07 | 172 | 60 | 6 | e37c0b5b547a7345179ab258dd2141fec7064c17 | |
| ToppCell | LA-01._Fibroblast_I|LA / Chamber and Cluster_Paper | 1.53e-07 | 179 | 60 | 6 | dcb6ec9ae72b13fe388b72dace2815293fafe8ee | |
| ToppCell | facs-Lung-24m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l25|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.58e-07 | 180 | 60 | 6 | baa5825e6ce23a98d9c21d024a4b0ab8ba353d0c | |
| ToppCell | facs-Lung-24m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.58e-07 | 180 | 60 | 6 | 2d608b9394d28d19cfc85c6ac94003d5177c8a92 | |
| ToppCell | facs-Lung-24m-Endothelial-arterial_endothelial|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.58e-07 | 180 | 60 | 6 | 0f9b27054358c4737eed06c8ea01987cccc3cb55 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.63e-07 | 181 | 60 | 6 | 9c157de9d3403e092c907599f2a2c16db5b21131 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.63e-07 | 181 | 60 | 6 | eea943fdcbef0bbaa8578f3296923e874893b405 | |
| ToppCell | 5'-Adult-LymphNode-Endothelial-blood_vessel_EC-Mature_arterial_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.68e-07 | 182 | 60 | 6 | 0639011cdd1c437ea8b7230896a4e6e5d7244ac2 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.74e-07 | 183 | 60 | 6 | bc7dd6a40ec9c773d005c1a46f305d40cdd0a326 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Endothelial-blood_vessel_EC-Fetal_arterial_EC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.86e-07 | 185 | 60 | 6 | 602536a3308a848f106adcb0a83530997440c8f4 | |
| ToppCell | droplet-Lung-LUNG-1m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-07 | 186 | 60 | 6 | 1e67bfb248366d7395efdd2d5e70a97bdb2e68af | |
| ToppCell | droplet-Lung-1m-Endothelial-arterial_endothelial|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.91e-07 | 186 | 60 | 6 | ffbc78058be8f0dc2e0335cc4c3195a636d17721 | |
| ToppCell | droplet-Lung-1m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.91e-07 | 186 | 60 | 6 | ed924852cd7132c8f6703522037dc22bd2c83193 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.91e-07 | 186 | 60 | 6 | 7582b5154d8e5a4434817b5ab77a10b789ea2288 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.4.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.91e-07 | 186 | 60 | 6 | 07d94d5d1c2fe7bb909a07ca81058a0eabc65c60 | |
| ToppCell | LA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 1.98e-07 | 187 | 60 | 6 | 4ea486991f66c29728d127171a07b81404ec0b78 | |
| ToppCell | PCW_05-06-Endothelial-Endothelial_mature-endo_venous_(13)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 1.98e-07 | 187 | 60 | 6 | 03de3c2df31bca0dc4e3718bada708d8fe8b69b9 | |
| ToppCell | -Donor_07|World / lung cells shred on cell class, cell subclass, sample id | 2.04e-07 | 188 | 60 | 6 | 038f48e8daaeb72716e975d22a6b004a90654960 | |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.04e-07 | 188 | 60 | 6 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_osteo-stroma-chondrocyte|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 2.04e-07 | 188 | 60 | 6 | 5a89587ee6f2b4dc14244bd88bb31efb81c50dbe | |
| ToppCell | Endothelial-endothelial_cell_of_artery|World / Lineage, Cell type, age group and donor | 2.10e-07 | 189 | 60 | 6 | fdd89c71113ac99b7c800c6def8888e512ff1128 | |
| ToppCell | droplet-Lung-immune-endo-depleted|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.10e-07 | 189 | 60 | 6 | c3fb363bb0156ffb3367c200f548faebda64ab4a | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.10e-07 | 189 | 60 | 6 | 2a2953f6b1b7d070d739dcaf7285fce6e097d9e4 | |
| ToppCell | droplet-Lung-3m|Lung / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.10e-07 | 189 | 60 | 6 | 5a636e952da9b1fd26aa17f7b129054f2da322b5 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-07 | 190 | 60 | 6 | 9cd147a174017ebda23cc47b6d4552d898acd092 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-07 | 190 | 60 | 6 | 9b825b2586c7b173ff27fcf2abc5860faf50984a | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.17e-07 | 190 | 60 | 6 | 4f775ee24b14733f06ae40b45f2dc1a0f0df0705 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-07 | 190 | 60 | 6 | d146af1926474328a7c822bc140c4dda66e1bbfb | |
| ToppCell | 3'-Child04-06-SmallIntestine-Endothelial-blood_vessel_EC-Mature_arterial_EC|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.17e-07 | 190 | 60 | 6 | ec6b8e2852e1cce0217ff61243defe98b2351640 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-07 | 191 | 60 | 6 | b7a57691a4742070cee640e285c1f4d0da95baf1 | |
| ToppCell | 5'-Adult-Appendix-Endothelial-blood_vessel_EC-Mature_arterial_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.24e-07 | 191 | 60 | 6 | adb2e3efcad02889d8229325080da5e7830fd3ae | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.24e-07 | 191 | 60 | 6 | 0fae1c2ef9f83ac7721d0a9d69455bf97eed9257 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-07 | 191 | 60 | 6 | 2f733d510a4862565a817f59829d8387d7ea26d9 | |
| ToppCell | facs-Mammary_Gland-Mammary_Gland-21m-Epithelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.24e-07 | 191 | 60 | 6 | 8691eba35793e4e90f93d50c2145847ee51289f7 | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.31e-07 | 192 | 60 | 6 | ad48c941a3ddfd9a5146bafc2209da577bb50531 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.31e-07 | 192 | 60 | 6 | 29bee88b45e23f16543ffc7cc361bc5da5d16a2b | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.31e-07 | 192 | 60 | 6 | b9e4585bea280ca0ae159f0c6a2bf7b88a15a6e6 | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.31e-07 | 192 | 60 | 6 | cdc652dbfabe41b324fd85c1ed933d29fb73a49f | |
| ToppCell | PND03-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF2-AF2_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.31e-07 | 192 | 60 | 6 | 19b94f254d51b9bda3d9b7c6f85e27ecb58409c8 | |
| ToppCell | droplet-Lung-30m-Mesenchymal-fibroblast-adventitial_fibroblast|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.38e-07 | 193 | 60 | 6 | 9d0b966d13cbce97beb43de6dc77f006c363a181 | |
| ToppCell | IPF-Endothelial-VE_Arterial|IPF / Disease state, Lineage and Cell class | 2.38e-07 | 193 | 60 | 6 | bf83b1fe9d38408f30eee4eb634341c04ef82791 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_adventitial_fibro_(10)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.38e-07 | 193 | 60 | 6 | adc9fc94f9ec686a417d08c0b8b7b7ab687afec0 | |
| ToppCell | IPF-Endothelial-VE_Arterial|World / Disease state, Lineage and Cell class | 2.38e-07 | 193 | 60 | 6 | 70a9aadda83a97e06e9bc2d1327ce60dd3c58767 | |
| ToppCell | PCW_10-12-Endothelial-Endothelial_mature-endo_venous_(13)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.45e-07 | 194 | 60 | 6 | efd5efed060edb7f24d59600981bb60ec28ac2ef | |
| ToppCell | 15-Airway-Endothelial|Airway / Age, Tissue, Lineage and Cell class | 2.45e-07 | 194 | 60 | 6 | ac0e48b0c09a7f57d30dff321b0c30a4c5e16ad9 | |
| ToppCell | droplet-Mammary_Gland-nan-18m-Epithelial-basal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.45e-07 | 194 | 60 | 6 | a516839871c4e9683093a1c07b72c682f9ecbb3d | |
| ToppCell | 15-Airway-Endothelial-Endothelial|Airway / Age, Tissue, Lineage and Cell class | 2.45e-07 | 194 | 60 | 6 | f3851337a2d17f4acef2cd812a766eb0b503748b | |
| ToppCell | (6)_Endothelial-B_(Artery)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 2.45e-07 | 194 | 60 | 6 | 0cf4e67d4024652794b5bfdd4a71a7d98900b4c8 | |
| ToppCell | 18-Distal-Mesenchymal-Mesenchyme_SERPINF1-high|Distal / Age, Tissue, Lineage and Cell class | 2.53e-07 | 195 | 60 | 6 | f86737bff21d81673238813df61a15cfe88d0b15 | |
| ToppCell | PCW_05-06-Endothelial-Endothelial_mature|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.53e-07 | 195 | 60 | 6 | 54fde2cfa51ab3a2d48d2426494ca6f0ce77f725 | |
| ToppCell | COVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type | 2.53e-07 | 195 | 60 | 6 | f423baa36ac7cdc383c033e35a7d17e6bf913323 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.53e-07 | 195 | 60 | 6 | 1236dc60288c7dd91868e86e9174a2dacd3b11b3 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Endothelial-blood_vessel_EC-Fetal_venous_EC|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.53e-07 | 195 | 60 | 6 | 752a100297c26732e12bbbf3ab27a2bd4f5ea06d | |
| ToppCell | droplet-Bladder-nan-3m-Epithelial-bladder_mesenchymal_cell_(Car3+)|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.53e-07 | 195 | 60 | 6 | 095b8e0be385b6390420589124a95fa4ba3682ab | |
| ToppCell | PND28-Mesenchymal|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.61e-07 | 196 | 60 | 6 | 119265efd2219f328d8152dbee52af8327aec89c | |
| ToppCell | Control-Stromal-Fibroblast|Control / Disease state, Lineage and Cell class | 2.61e-07 | 196 | 60 | 6 | 7ca94477498a84cafcdd9933ee92a6cbde76c70e | |
| ToppCell | Control-Stromal-Fibroblast|World / Disease state, Lineage and Cell class | 2.61e-07 | 196 | 60 | 6 | 1ec7a4daa51b3156db97e1fd6cb925ad311bb4b5 | |
| ToppCell | 5'-Adult-LargeIntestine-Endothelial-blood_vessel_EC-Mature_arterial_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.69e-07 | 197 | 60 | 6 | 61b1b10a017cbeb17f8529fcae66cba77ee2f115 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal-fibroblastic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.69e-07 | 197 | 60 | 6 | ab5d3ebc73bd7cfc64381d14b92878b370205186 | |
| ToppCell | 5'-Adult-Appendix-Mesenchymal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.69e-07 | 197 | 60 | 6 | b11a5d909942a4299cbc0b27332b1a3f66f3bccd | |
| ToppCell | 5'-Adult-Appendix-Endothelial-blood_vessel_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.69e-07 | 197 | 60 | 6 | e8e879b7634a29569061d3515d180784094a31e7 | |
| ToppCell | 11.5-Airway-Mesenchymal-Mesenchyme_SERPINF1-high|Airway / Age, Tissue, Lineage and Cell class | 2.69e-07 | 197 | 60 | 6 | 9a053a32ff9c3a85ef9a3382453acd619cc48546 | |
| ToppCell | Fibroblasts-DKK3+_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 2.77e-07 | 198 | 60 | 6 | 4f4632f26a2043c5e4ab89031b4229b5dca1bd48 | |
| ToppCell | tumor_Lung-Fibroblasts-Myofibroblasts|tumor_Lung / Location, Cell class and cell subclass | 2.77e-07 | 198 | 60 | 6 | 31f9181dab689aabe9c6182c2ef7de65ba3f0ff6 | |
| ToppCell | distal-mesenchymal-Myofibroblast-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.77e-07 | 198 | 60 | 6 | beef5075ba6dcd4d0a447bc4e57efcaf2e93c546 | |
| ToppCell | Non-neuronal-Postmitotic-Mural-Mural|World / Primary Cells by Cluster | 2.77e-07 | 198 | 60 | 6 | 9fc1035ea447a4551a66944c869c4671e17cec61 | |
| ToppCell | Tracheal-10x5prime-Stromal-Chondrocytic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.77e-07 | 198 | 60 | 6 | c72ef2ddcbb6dacbed4c6200d89e17d57314dcdc | |
| ToppCell | ILEUM-inflamed-(7)_CD36+_endothelial_cells|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 2.77e-07 | 198 | 60 | 6 | 05d6558c7990ad2277db999025a073d29b273dfc | |
| ToppCell | 5'-Adult-Distal_Rectal-Endothelial-blood_vessel_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.77e-07 | 198 | 60 | 6 | d1f54ed3ef5e05ebda7da999e172d168dc6802cd | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Endothelial-blood_vessel_EC-arterial_capillary|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.77e-07 | 198 | 60 | 6 | e9e98c20ff7b3f3851db86381550ce7085e2db9e | |
| ToppCell | Control-Stromal|Control / Disease state, Lineage and Cell class | 2.77e-07 | 198 | 60 | 6 | ae726b6b7f0a4107899be4d32ac256ffa0bd8d59 | |
| ToppCell | 5'-Adult-Distal_Rectal-Endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.77e-07 | 198 | 60 | 6 | 8d6b0b9da7c1e64155cbcbb04ad38d129a29030c | |
| ToppCell | Non-neuronal-Postmitotic-Mural|World / Primary Cells by Cluster | 2.77e-07 | 198 | 60 | 6 | dd38840a96171f58da243daa22b013e15a81db4a | |
| ToppCell | Tracheal-10x5prime-Stromal-Chondrocytic-Chondrocyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.77e-07 | 198 | 60 | 6 | 55f013e9e6587d9ece59751fa131b1d22d6cceea | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.77e-07 | 198 | 60 | 6 | 1b90d632e59c3c47b936e829cceeb0334f05f34f | |
| ToppCell | Non-neuronal-Postmitotic-Mural-Mural-18|World / Primary Cells by Cluster | 2.77e-07 | 198 | 60 | 6 | 21efb7bcd24f24d20791b34e75d6f9d46a129481 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.77e-07 | 198 | 60 | 6 | aae663c6da70b6e716edeed50cc7d3962d78e697 | |
| Computational | Adhesion molecules. | 5.82e-08 | 141 | 42 | 8 | MODULE_122 | |
| Computational | Placenta genes. | TGFB1 COL2A1 COL5A2 HSPG2 COL6A2 VWF IGFBP3 IKBKG PLCB2 STAB1 | 8.47e-06 | 463 | 42 | 10 | MODULE_38 |
| Computational | ECM and collagens. | 2.32e-05 | 225 | 42 | 7 | MODULE_47 | |
| Computational | Cell line expressed genes. | 2.26e-04 | 432 | 42 | 8 | MODULE_52 | |
| Computational | Thymus genes. | 2.35e-04 | 325 | 42 | 7 | MODULE_44 | |
| Computational | Fetal liver genes - metabolism and xenobiotics. | 3.12e-04 | 453 | 42 | 8 | MODULE_24 | |
| Computational | Ovary genes. | 4.99e-04 | 368 | 42 | 7 | MODULE_1 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 9.57e-04 | 50 | 42 | 3 | GAVISH_3CA_METAPROGRAM_ENDOTHELIAL_NOTCH_SIGNALING | |
| Computational | Trachea genes. | 1.02e-03 | 415 | 42 | 7 | MODULE_6 | |
| Computational | Heart, liver, kidney and pancreas metabolic and xenobiotic response genes. | COL2A1 COL5A2 HSPG2 COL6A2 VWF IGFBP3 IKBKG C4BPA PLCB2 STAB1 | 1.13e-03 | 835 | 42 | 10 | MODULE_88 |
| Drug | LMWH | TGFB1 COL2A1 PAPPA2 HSPG2 COL6A2 LAMB4 CPAMD8 THBD VWF IGFBP3 SPOCK1 LAMA2 LAMA3 C4BPA ADAMTSL4 | 1.24e-10 | 663 | 60 | 15 | CID000000772 |
| Drug | chondroitin sulfate | TGFB1 COL2A1 PAPPA2 HSPG2 COL6A2 THBD FMOD SPOCK1 PRELP LAMA3 ADAMTSL4 | 9.46e-09 | 413 | 60 | 11 | CID000024766 |
| Drug | Rgd Peptide | 1.24e-08 | 239 | 60 | 9 | CID000104802 | |
| Drug | dermatan sulfate | 1.11e-07 | 220 | 60 | 8 | CID000032756 | |
| Drug | kalinin | 3.37e-07 | 55 | 60 | 5 | CID000032518 | |
| Drug | AC1L1G72 | 2.83e-06 | 11 | 60 | 3 | CID000003553 | |
| Drug | strontium phosphate | 3.76e-06 | 12 | 60 | 3 | CID000159737 | |
| Drug | AC1L1KMJ | 4.06e-06 | 476 | 60 | 9 | CID000030956 | |
| Drug | 1zd2 | 5.99e-06 | 45 | 60 | 4 | CID004149241 | |
| Drug | AC1L1C2F | 1.06e-05 | 110 | 60 | 5 | CID000001711 | |
| Drug | Amiodarone hydrochloride [19774-82-4]; Up 200; 5.8uM; MCF7; HT_HG-U133A | 1.28e-05 | 196 | 60 | 6 | 5253_UP | |
| Drug | Tetrahydroxy-1,4-quinone monohydrate [319-89-1]; Up 200; 21uM; HL60; HT_HG-U133A | 1.28e-05 | 196 | 60 | 6 | 2999_UP | |
| Drug | alpha-estradiol; Up 200; 0.01uM; MCF7; HG-U133A | 1.40e-05 | 199 | 60 | 6 | 122_UP | |
| Drug | lutein G | 1.66e-05 | 58 | 60 | 4 | CID000181579 | |
| Drug | (2s,5s)-5-Carboxymethylproline | 1.83e-05 | 314 | 60 | 7 | CID000447989 | |
| Drug | DMSe | 2.57e-05 | 132 | 60 | 5 | CID000020796 | |
| Drug | p-chlorophenyl methyl sulfoxide | 4.08e-05 | 4 | 60 | 2 | CID000013626 | |
| Drug | YIGSR | 5.65e-05 | 79 | 60 | 4 | CID000123977 | |
| Drug | AC1L1B58 | 6.05e-05 | 29 | 60 | 3 | CID000001288 | |
| Drug | hyaluronan | 6.66e-05 | 263 | 60 | 6 | CID000024759 | |
| Drug | 2-[(1R,2R,3S,4R,5R,6S)-2-[(2R,5S)-3-[(3S,4S,5R,6S)-4,5-dihydroxy-3-(methylamino)-6-methylol-tetrahydropyran-2-yl]-4-formyl-4-hydroxy-5-methylol-tetrahydrofuran-2-yl]oxy-5-guanidino-3,4,6-trihydroxy-cyclohexyl]guanidine | 6.85e-05 | 83 | 60 | 4 | CID011968896 | |
| Drug | valnoctamide | 7.42e-05 | 31 | 60 | 3 | CID000020140 | |
| Drug | 1,2-dimethylhydrazine | 7.87e-05 | 86 | 60 | 4 | CID000001322 | |
| Drug | palbociclib | 8.81e-05 | 171 | 60 | 5 | ctd:C500026 | |
| Drug | sulfate | COL2A1 HSPG2 COL6A2 LAMB4 VWF FMOD SPOCK1 PRELP LAMA2 LAMA3 PLCB2 ADAMTSL4 | 1.17e-04 | 1292 | 60 | 12 | CID000001117 |
| Drug | 1-alpha-25-dihydroxycholecalciferol | TGFB1 COL2A1 JAG2 LAMB4 NELL2 IGFBP3 LAMA2 LAMA3 PLCB2 GFRA3 | 1.20e-04 | 909 | 60 | 10 | CID000002524 |
| Disease | Spondyloepiphyseal Dysplasia | 3.76e-06 | 16 | 57 | 3 | C0038015 | |
| Disease | Spondyloepiphyseal Dysplasia Tarda, X-Linked | 3.76e-06 | 16 | 57 | 3 | C3541456 | |
| Disease | Schwartz-Jampel Syndrome, Type 1 | 3.76e-06 | 16 | 57 | 3 | C4551479 | |
| Disease | Schwartz-Jampel Syndrome | 3.76e-06 | 16 | 57 | 3 | C0036391 | |
| Disease | Melnick-Needles Syndrome | 3.76e-06 | 16 | 57 | 3 | C0025237 | |
| Disease | Van Buchem disease | 4.56e-06 | 17 | 57 | 3 | C0432272 | |
| Disease | osteochondrodysplasia (is_implicated_in) | 6.48e-06 | 19 | 57 | 3 | DOID:2256 (is_implicated_in) | |
| Disease | Osteochondrodysplasias | 6.48e-06 | 19 | 57 | 3 | C0029422 | |
| Disease | carotid artery disease (is_marker_for) | 6.48e-06 | 19 | 57 | 3 | DOID:3407 (is_marker_for) | |
| Disease | Dyschondroplasias | 6.48e-06 | 19 | 57 | 3 | C0013366 | |
| Disease | Multiple Epiphyseal Dysplasia | 7.61e-06 | 20 | 57 | 3 | C0026760 | |
| Disease | Junctional epidermolysis bullosa | 1.10e-05 | 3 | 57 | 2 | cv:C0079301 | |
| Disease | Junctional epidermolysis bullosa gravis of Herlitz | 1.10e-05 | 3 | 57 | 2 | cv:C0079683 | |
| Disease | EPIDERMOLYSIS BULLOSA, JUNCTIONAL 1B, SEVERE | 1.10e-05 | 3 | 57 | 2 | 226700 | |
| Disease | lung small cell carcinoma (is_implicated_in) | 2.16e-05 | 28 | 57 | 3 | DOID:5409 (is_implicated_in) | |
| Disease | Herlitz Disease | 2.19e-05 | 4 | 57 | 2 | C0079683 | |
| Disease | Epidermolysis Bullosa Progressiva | 2.19e-05 | 4 | 57 | 2 | C0079297 | |
| Disease | Adult junctional epidermolysis bullosa (disorder) | 3.65e-05 | 5 | 57 | 2 | C0268374 | |
| Disease | EPIDERMOLYSIS BULLOSA, JUNCTIONAL, LOCALISATA VARIANT (disorder) | 3.65e-05 | 5 | 57 | 2 | C2608084 | |
| Disease | autosomal recessive limb-girdle muscular dystrophy (is_implicated_in) | 3.65e-05 | 5 | 57 | 2 | DOID:0110274 (is_implicated_in) | |
| Disease | junctional epidermolysis bullosa non-Herlitz type (implicated_via_orthology) | 3.65e-05 | 5 | 57 | 2 | DOID:0060738 (implicated_via_orthology) | |
| Disease | retinal detachment, retinal break | 4.28e-05 | 35 | 57 | 3 | EFO_0005773, EFO_0010698 | |
| Disease | Behcet's disease (is_implicated_in) | 4.66e-05 | 36 | 57 | 3 | DOID:13241 (is_implicated_in) | |
| Disease | Junctional Epidermolysis Bullosa | 5.47e-05 | 6 | 57 | 2 | C0079301 | |
| Disease | familial combined hyperlipidemia (is_marker_for) | 5.47e-05 | 6 | 57 | 2 | DOID:13809 (is_marker_for) | |
| Disease | junctional epidermolysis bullosa (is_implicated_in) | 7.65e-05 | 7 | 57 | 2 | DOID:3209 (is_implicated_in) | |
| Disease | Amelogenesis imperfecta local hypoplastic form | 7.65e-05 | 7 | 57 | 2 | C0399367 | |
| Disease | ankylosing spondylitis (is_marker_for) | 1.63e-04 | 10 | 57 | 2 | DOID:7147 (is_marker_for) | |
| Disease | Retinal Detachment | 1.99e-04 | 11 | 57 | 2 | C0035305 | |
| Disease | Craniofacial Abnormalities | 2.39e-04 | 156 | 57 | 4 | C0376634 | |
| Disease | colon carcinoma (is_marker_for) | 2.82e-04 | 13 | 57 | 2 | DOID:1520 (is_marker_for) | |
| Disease | type 1 diabetes mellitus (is_marker_for) | 3.71e-04 | 72 | 57 | 3 | DOID:9744 (is_marker_for) | |
| Disease | Lymphoma, Follicular, Grade 2 | 3.79e-04 | 15 | 57 | 2 | C1956132 | |
| Disease | Lymphoma, Follicular, Grade 3 | 3.79e-04 | 15 | 57 | 2 | C1956131 | |
| Disease | Lymphoma, Follicular, Grade 1 | 3.79e-04 | 15 | 57 | 2 | C1956130 | |
| Disease | Lymphoma, Large-Cell, Follicular | 3.79e-04 | 15 | 57 | 2 | C0079745 | |
| Disease | Lymphoma, Small Cleaved-Cell, Follicular | 3.79e-04 | 15 | 57 | 2 | C0079765 | |
| Disease | Lymphoma, Mixed-Cell, Follicular | 3.79e-04 | 15 | 57 | 2 | C0079758 | |
| Disease | Myopia | 3.79e-04 | 15 | 57 | 2 | C0027092 | |
| Disease | myopia (is_implicated_in) | 4.32e-04 | 16 | 57 | 2 | DOID:11830 (is_implicated_in) | |
| Disease | IGF-1 measurement, IGFBP-3 measurement | 4.89e-04 | 17 | 57 | 2 | EFO_0004626, EFO_0004627 | |
| Disease | inflammatory bowel disease (is_implicated_in) | 6.14e-04 | 19 | 57 | 2 | DOID:0050589 (is_implicated_in) | |
| Disease | liver fibrosis measurement | 6.24e-04 | 86 | 57 | 3 | EFO_0010576 | |
| Disease | Lymphoma, Follicular | 6.81e-04 | 20 | 57 | 2 | C0024301 | |
| Disease | Liver Cirrhosis, Experimental | 7.03e-04 | 774 | 57 | 7 | C0023893 | |
| Disease | Degenerative polyarthritis | 7.84e-04 | 93 | 57 | 3 | C0029408 | |
| Disease | Osteoarthrosis Deformans | 7.84e-04 | 93 | 57 | 3 | C0086743 | |
| Disease | impotence (biomarker_via_orthology) | 8.26e-04 | 22 | 57 | 2 | DOID:1875 (biomarker_via_orthology) | |
| Disease | hypertension (biomarker_via_orthology) | 9.79e-04 | 227 | 57 | 4 | DOID:10763 (biomarker_via_orthology) | |
| Disease | obesity (is_marker_for) | 9.96e-04 | 101 | 57 | 3 | DOID:9970 (is_marker_for) | |
| Disease | Prostatic Neoplasms | 1.19e-03 | 616 | 57 | 6 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 1.19e-03 | 616 | 57 | 6 | C0376358 | |
| Disease | apolipoprotein A 1 measurement | 1.20e-03 | 848 | 57 | 7 | EFO_0004614 | |
| Disease | Early Pregnancy Loss | 1.24e-03 | 109 | 57 | 3 | C3830362 | |
| Disease | Spontaneous abortion | 1.24e-03 | 109 | 57 | 3 | C0000786 | |
| Disease | Miscarriage | 1.24e-03 | 109 | 57 | 3 | C4552766 | |
| Disease | Abortion, Tubal | 1.24e-03 | 109 | 57 | 3 | C0000822 | |
| Disease | chronic myeloid leukemia (is_marker_for) | 1.25e-03 | 27 | 57 | 2 | DOID:8552 (is_marker_for) | |
| Disease | cortical thickness | 1.28e-03 | 1113 | 57 | 8 | EFO_0004840 | |
| Disease | Hyperplasia | 1.34e-03 | 28 | 57 | 2 | C0020507 | |
| Disease | factor VIII measurement, coronary artery disease | 1.38e-03 | 113 | 57 | 3 | EFO_0001645, EFO_0004630 | |
| Disease | arteriosclerosis (is_marker_for) | 1.44e-03 | 29 | 57 | 2 | DOID:2349 (is_marker_for) | |
| Disease | factor XI measurement, venous thromboembolism | 1.54e-03 | 30 | 57 | 2 | EFO_0004286, EFO_0004694 | |
| Disease | pulmonary hypertension (is_implicated_in) | 1.54e-03 | 30 | 57 | 2 | DOID:6432 (is_implicated_in) | |
| Disease | von Willebrand factor measurement, coronary artery disease | 1.56e-03 | 118 | 57 | 3 | EFO_0001645, EFO_0004629 | |
| Disease | internet addiction disorder | 1.86e-03 | 33 | 57 | 2 | EFO_0803368 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PPACEPNSCINLPDI | 291 | P04003 | |
| LRACSQAPCPPEQPD | 371 | Q6UY14 | |
| PPEALDCPACCLAKL | 566 | Q13939 | |
| CSLPDPCDSNPCPAN | 1791 | Q9HCU4 | |
| PCAPLEDECEAPLVC | 206 | Q9NYJ7 | |
| PVLCICSADDPVCGP | 351 | Q6UXT9 | |
| LSPEIPFGECCPICP | 76 | P02458 | |
| TPEDCQPCACPLTNP | 1606 | P98160 | |
| ACLPDLAACVPDLPP | 736 | O75106 | |
| PGCTLPCPCDADNTI | 356 | A6BM72 | |
| PDPRDCPQECDCPPN | 71 | Q06828 | |
| CPQECDCPPNFPTAM | 76 | Q06828 | |
| PRCAPEPDAFNPCED | 341 | P22888 | |
| PVDAPDGCIPCSCDP | 416 | Q16787 | |
| IQCETLICPNPDCPL | 301 | Q99435 | |
| NPTVDLFCCPECDPR | 681 | Q99435 | |
| PLCEVDVDLCEPSPC | 531 | Q9Y219 | |
| FCELCPPETDPPATN | 601 | Q96KR4 | |
| QPCDHPRQPCDSSCP | 521 | Q15910 | |
| SLLQPICCDTCPPPC | 41 | Q9BYR8 | |
| EDCFQILDDCPPPPA | 251 | Q9H1R3 | |
| AVPQVTSPPCCLCPE | 61 | Q32NB8 | |
| RSPPEEPPDFCCPKC | 386 | Q9Y6K9 | |
| WLLEPICCDNCPPPC | 41 | Q9BYR7 | |
| WLLEPTCCDNCPPPC | 41 | Q9BYR6 | |
| SEDCQPCACPLNIPS | 801 | P24043 | |
| PDCAPAAPSLPQDPC | 276 | P21917 | |
| CENLQGECPPPPSEL | 1646 | Q9BXP8 | |
| CLLEPCIPSVPQCLP | 276 | Q9BV87 | |
| APNCALPPVAPNCLE | 236 | O60609 | |
| APLEPAPPSCCALEQ | 1746 | Q8IZJ3 | |
| CPDPQIVCPDLPCQT | 806 | P12110 | |
| SPAEEEPAPCKDCQP | 316 | Q6UXB0 | |
| EPAPCKDCQPLCPPL | 321 | Q6UXB0 | |
| DCADPVTPPGECCPV | 81 | P05997 | |
| CTPISCPGELCPQDN | 796 | Q13751 | |
| ATDPLGCQPCDCNPL | 446 | A4D0S4 | |
| QPCRPCLCPDDPSSN | 906 | A4D0S4 | |
| EPCDARALAQCAPPP | 41 | P17936 | |
| ACCCAPQPAEDEPPA | 196 | Q5VY09 | |
| VDDCILEPSPCPQRC | 326 | P07204 | |
| PCAPCPLTCDDISGQ | 1821 | A2VEC9 | |
| FPIPVACDAPCPKDC | 621 | Q9UPZ6 | |
| ECLQPCLQVPSPLCP | 56 | Q96A37 | |
| PDSPCSCDCFVSVPP | 6 | Q96FV2 | |
| CPEPVLLPGECCPQC | 646 | Q6ZWJ8 | |
| LLPGECCPQCPAAPA | 651 | Q6ZWJ8 | |
| PALCPFPARGDCCPD | 766 | Q6ZWJ8 | |
| EFPDPREPCNLCTCL | 796 | Q6ZWJ8 | |
| PDCPRECYCPPDFPS | 71 | P51888 | |
| CTPPALPPCARECQS | 471 | Q6ZRI6 | |
| CPCLCTEEGPLCAQP | 176 | Q2TAL6 | |
| PICCSLFDDPRVLPC | 11 | O60858 | |
| VCDPVSCDLPPVPHC | 2326 | P04275 | |
| LCAPAEAAPCPAEPE | 161 | Q86UD0 | |
| DCKDPYCPPSLCQVP | 221 | Q9P2F5 | |
| SAAPCCVPQALEPLP | 351 | P01137 | |
| SLATLCDGPCPCLPE | 171 | Q08629 | |
| EPYLPPCQDQCPPQC | 71 | Q5T870 | |
| LQPVCTPPCAPEAVC | 2056 | Q9NY15 | |
| CECLPSPGLEPEPCS | 6 | Q9Y6S9 | |
| PQLEVPCCLCPLKSE | 651 | Q9Y4R7 | |
| ACECPPELCEQDPLI | 1161 | Q00722 | |
| ELPSCACCCEPQPSP | 706 | Q9ULT6 | |
| PPLPDQCPALCECSE | 56 | Q13641 | |
| PPTEQACLIPCPRDC | 166 | Q9C0I4 | |
| SPQPEEPCLCAVPEE | 771 | O14686 |